we report also that the histidinol-mediated protection to bone marrow cells persists in l1210 leukemia-bearing dba/2j mice treated with combinations of histidinol and 1-beta-d-arabinofuranosylcytosine or 5-fluorouracil without diminishing the toxicities of these agents for in situ leukemia cells .
C0005953
bone marrow
C0023418
cells